This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Mukhopadhyay, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Mukhopadhyay, D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 2007, p. 7345-7353, Vol. 27, No. 20
0270-7306/07/$08.00+0     doi:10.1128/MCB.02201-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Protein Kinase C-Mediated Modulation of FIH-1 Expression by the Homeodomain Protein CDP/Cut/Cux{triangledown}

Jinping Li,1 Enfeng Wang,1 Shamit Dutta,1 Julie S. Lau,1 Shi-wen Jiang,2 Kaustubh Datta,1 and Debabrata Mukhopadhyay1*

Department of Biochemistry and Molecular Biology,1 Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, Rochester, Minnesota 559052

Received 23 November 2006/ Returned for modification 3 January 2007/ Accepted 20 July 2007

Under normoxia, FIH-1 (factor inhibiting HIF-1) inhibits the transcriptional activity of hypoxia-inducible factor (HIF); however, under such conditions, we observed a significant level of HIF activity in renal cell carcinoma (RCC). This phenomenon could be attributed to a decrease in the level of functional FIH that has been identified in our previous work. Nonetheless, the molecular mechanism of FIH regulation in cancer, in particular RCC, was unclear until now. In this communication, we have demonstrated that in RCC, the Cut-like homeodomain protein (CDP/Cut) is involved in FIH transcriptional regulation and is controlled by a specific signaling event involving protein kinase C (PKC) {zeta}. Furthermore, we have defined a unique CDP/Cut binding site on the FIH promoter. With chromatin immunoprecipitation assays, we show that CDP binds to the FIH-1 promoter in vivo and that this binding is PKC {zeta} dependent. Moreover, we have also defined a potential phosphorylation site in CDP (serine 987) that modulates FIH expression. CDP/Cut is a transcriptional repressor that decreases FIH-1 expression and subsequently leads to a decrease in the repressor activity of FIH-1. Without this repression, HIF activity increases, allowing for the increased transcription of the genes it regulates, such as the vascular endothelial growth factor and GLUT-1 genes. Both CDP and HIF levels are increased in several cancers and are responsible for the metastatic progression of the tumors. Taken together, our results suggest for the first time a potential connection between CDP and FIH that could lead to the development of future therapeutic interventions.

* Corresponding author. Mailing address: Department of Biochemistry and Molecular Biology, Gugg 1401A, Mayo Clinic College of Medicine, 200 First Street SW, Rochester MN 55905. Phone: (507) 538-3581. Fax: (507) 284-1767. E-mail: mukhopadhyay.debabrata{at}mayo.edu

{triangledown} Published ahead of print on 6 August 2007.

Molecular and Cellular Biology, October 2007, p. 7345-7353, Vol. 27, No. 20
0270-7306/07/$08.00+0     doi:10.1128/MCB.02201-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»